Coursera Plus Annual Sale:
All Certificates & Courses 40% Off!
Grab it
Explore cutting-edge cell-based treatments for systemic sclerosis in this 49-minute patient forum session from the Scleroderma Research Foundation. Begin with an overview of the cell therapy landscape in scleroderma research presented by Luke Evnin, PhD, Chairman of the Board at the Scleroderma Research Foundation. Discover insights from leading experts Ryan Crisman, PhD from Umoja Biopharma and Elaine Karis, MD from Bristol Myers Squibb as they discuss CAR T Cell Therapy as a potential "fresh start" for the immune system and examine next-generation cell therapies on the horizon for patients. Learn about this emerging area of interest in scleroderma research and understand what scientists are currently exploring in cell-based treatment approaches for systemic sclerosis. This session was originally presented on June 2, 2025, as part of the 4th annual SRF Patient Forum titled "Collaborating for a Cure."
